Heart hormone trial aims to calm chaotic heartbeats
NCT ID NCT07359872
Summary
This study is testing whether adding a natural hormone called Relaxin to standard catheter ablation treatment can better control atrial fibrillation (AFib) in veterans. Researchers want to see if Relaxin reduces oxidative stress in the heart and lowers how often AFib returns after the procedure. The trial will involve 208 veterans with symptomatic AFib who haven't been helped enough by medications and are scheduled for an ablation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.